Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Payables (2022 - 2025)

Envoy Medical's Payables history spans 4 years, with the latest figure at $6.7 million for Q4 2025.

  • Quarterly results put Payables at $6.7 million for Q4 2025, up 185.87% from a year ago — trailing twelve months through Dec 2025 was $6.7 million (up 185.87% YoY), and the annual figure for FY2025 was $6.7 million, up 185.87%.
  • Payables for Q4 2025 was $6.7 million at Envoy Medical, up from $5.3 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $7.4 million in Q3 2023 to a low of $658899.0 in Q1 2022.
  • The 4-year median for Payables is $1.6 million (2023), against an average of $2.5 million.
  • The sharpest move saw Payables skyrocketed 588.95% in 2023, then plummeted 76.2% in 2024.
  • Year by year, Payables stood at $1.5 million in 2022, then grew by 7.1% to $1.6 million in 2023, then soared by 50.77% to $2.3 million in 2024, then soared by 185.87% to $6.7 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $6.7 million, $5.3 million, and $3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.